Skip to main content
. 2017 May 17;4:8–14. doi: 10.1016/j.ctro.2017.04.004

Table 3.

Pathological tumor response.

All (N = 2094) Group 1: TME within 6 weeks (N = 300) Group 2: TME between 7 and 12 weeks (N = 1598) Group 3: TME ≥13 weeks (N = 196) P value
pCR, N (%) 468 (22.3%) 38 (12.6%) 369 (23%) 61 (31.1%) p < 0.01
pPR, N (%) 1139 (54.4%) 140 (46.6%) 877(54.8%) 122 (62.2%) p < 0.01

Data are pCR and pPR events number (%). p value tests the null hypothesis of equal proportions across study groups (Pearson's Chi square test).